Prediction of drug clearance in children from adults: a comparison of several allometric methods

Iftekhar Mahmood1

  • 1Clinical Pharmacology and Toxicology Branch, Office of Drug Evaluation VI, Center for Drug Evaluation and Research, Food & Drug Administration, Rockville, MD 20852, USA. mahmoodi@cder.fda.gov

Insights

Predicting pediatric drug clearance requires careful consideration of exponents. This study found that exponents 0.75, 0.80, and 0.85 offer similar accuracy for predicting drug clearance in children, suggesting a combination of methods may be optimal.

Area of Science:

  • Pharmacokinetics
  • Pediatric Drug Development
  • Quantitative Pharmacology

Background:

  • Establishing safe and effective pediatric drug dosages is crucial.
  • Existing models for predicting pediatric drug clearance from adult data, such as CLchild=adult CLx(weightchild/70)^0.75, face controversy regarding the suitability of the 0.75 exponent.

Purpose of the Study:

  • To evaluate the accuracy of the 0.75 exponent for predicting pediatric drug clearance.
  • To identify alternative exponents or methods that improve prediction accuracy.
  • To propose a refined approach for pediatric drug clearance prediction.

Main Methods:

  • Evaluated multiple exponents (0.75, 0.80, 0.85, 1.0) for predicting pediatric drug clearance from adult data.
  • Assessed an empirical approach utilizing kidney and liver weights.
  • Introduced a sixth method based on the results of the initial five methods.

Main Results:

  • No single prediction method proved universally suitable for all drugs and pediatric age groups.
  • Exponents 0.75, 0.80, and 0.85 demonstrated comparable levels of accuracy and error in clearance prediction.
  • The study highlighted variability in prediction efficacy across different drugs and patient populations.

Conclusions:

  • A singular approach is insufficient for accurate pediatric drug clearance prediction.
  • Combining various predictive methods is recommended to enhance the accuracy of extrapolating adult drug clearance data to pediatric populations.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Clearance Models: Noncompartmental Models01:17

Clearance Models: Noncompartmental Models

Clearance is a pharmacokinetic parameter traditionally defined by compartment models, signifying the rate at which a drug is expelled from the body. However, a noncompartmental model offers an alternative method for assessing clearance, primarily employing empirical data obtained after administering a single drug dose.
The noncompartmental approach capitalizes on extensive sampling data, correlating the volume of distribution to systemic exposure and the administered dosage. This method enables...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance00:56

One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance

Clearance is a key pharmacokinetic parameter that quantifies the volume of body fluid from which a drug is entirely removed within a specific time frame. It is crucial in assessing how a drug is eliminated from the body and has critical clinical applications.
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...